Quidel reported $1.07B in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Abbott USD 16.15B 1.66B Sep/2026
Agilent USD 2.29B 20M Jun/2026
Becton, Dickinson and Co. USD 9.54B 139M Sep/2026
Bruker USD 1.17B 32.6M Sep/2026
Cerus USD 100.8M 12.37M Dec/2025
Charles River Laboratories USD 1.09B 45.49M Sep/2026
Danaher USD 9.05B 945M Sep/2026
Haemonetics USD 300.84M 37.6M Sep/2026
Illumina USD 1.16B 422M Sep/2026
IQVIA Holdings USD 7.78B 1.04B Sep/2026
Merit Medical Systems USD 265.08M 150K Sep/2026
Mettler Toledo International USD 1.25B 49.81M Sep/2026
Myriad Genetics USD 130.7M 500K Jun/2026
Neogen USD 149.5M 8.7M Jun/2026
OraSure Technologies USD 25.12M 18.96M Jun/2026
Pacific Biosciences Of California USD 66.59M 2.21M Sep/2026
Quidel USD 1.07B 73.7M Sep/2026
Revvity USD 701.48M 574.88M Sep/2026
STAAR Surgical USD 75.54M 2.15M Sep/2026
Thermo Fisher Scientific USD 14.17B 899M Sep/2026
Waters USD 2.4B 126M Jun/2026